Mouse models as tools to explore cytidine-to-uridine RNA editing.

RNA editing is a process through which the nucleotide sequence specified in the genomic template is modified to produce a different nucleotide sequence in the transcript. RNA editing is an important mechanism of genetic regulation that amplifies genetic plasticity by allowing the production of alternative protein products from a single gene. There are two generic classes of RNA editing in nuclei, involving enzymatic deamination of either C-to-U or A-to-I nucleotides. The best characterized example of C-to-U RNA editing is that of apolipoprotein B (apoB), which is mediated by a holoenzyme that contains a minimal core composed of an RNA-specific cytidine deaminase apobec-1, and its cofactor apobec-1 complementation factor (ACF). C-to-U editing of apoB RNA generates two different isoforms--apoB100 and apoB48--from a single transcript. Both are important regulators of lipid transport and metabolism, and are functionally distinct. C-to-U apoB RNA editing is regulated by a range of factors including developmental, nutritional, environmental, and metabolic stimuli. Rodent models have provided a tractable system in which to study the effects of such stimuli on lipid metabolism. In addition, both transgenic and gene knockout experiments have provided important insights into gain and loss of function approaches for studying C-to-U RNA editing in a murine background.

[1]  Robert V Farese,et al.  Targeted Disruption of the Mouse apobec-1 Gene Abolishes Apolipoprotein B mRNA Editing and Eliminates Apolipoprotein B48 (*) , 1996, The Journal of Biological Chemistry.

[2]  J. Scott,et al.  Thyroid hormone modulates the introduction of a stop codon in rat liver apolipoprotein B messenger RNA. , 1988, The Journal of biological chemistry.

[3]  R. Pease,et al.  A novel form of tissue-specific RNA processing produces apolipoprotein-B48 in intestine , 1987, Cell.

[4]  R. Davis,et al.  Dietary carbohydrate induces lipogenesis and very-low-density lipoprotein synthesis. , 1984, The American journal of physiology.

[5]  K. Kitagawa,et al.  Developmental and age-related changes in apolipoprotein B mRNA editing in mice. , 1992, Journal of lipid research.

[6]  N. Davidson,et al.  REPR and complementation factor(s) interact to modulate rat apolipoprotein B mRNA editing in response to alterations in cellular cholesterol flux. , 1994, Journal of lipid research.

[7]  R. König,et al.  Species-Specific Exclusion of APOBEC3G from HIV-1 Virions by Vif , 2003, Cell.

[8]  N. Sherman,et al.  Molecular Cloning of Apobec-1 Complementation Factor, a Novel RNA-Binding Protein Involved in the Editing of Apolipoprotein B mRNA , 2000, Molecular and Cellular Biology.

[9]  G. Ness,et al.  Thyroid hormone rapidly induces hepatic LDL receptor mRNA levels in hypophysectomized rats. , 1994, Archives of biochemistry and biophysics.

[10]  Nicholas O. Davidson,et al.  C-to-U RNA Editing: Mechanisms Leading to Genetic Diversity* , 2003, The Journal of Biological Chemistry.

[11]  T. Innerarity,et al.  A novel translational repressor mRNA is edited extensively in livers containing tumors caused by the transgene expression of the apoB mRNA-editing enzyme. , 1997, Genes & development.

[12]  N. Davidson,et al.  Tissue-specific, developmental and nutritional regulation of the gene encoding the catalytic subunit of the rat apolipoprotein B mRNA editing enzyme: functional role in the modulation of apoB mRNA editing. , 1995, Journal of lipid research.

[13]  F. Buck,et al.  Purification and Molecular Cloning of a Novel Essential Component of the Apolipoprotein B mRNA Editing Enzyme-Complex* , 2000, The Journal of Biological Chemistry.

[14]  M. Sowden,et al.  Metabolic regulation of ApoB mRNA editing is associated with phosphorylation of APOBEC-1 complementation factor , 2006, Nucleic acids research.

[15]  D. Viskochil,et al.  C-->U editing of neurofibromatosis 1 mRNA occurs in tumors that express both the type II transcript and apobec-1, the catalytic subunit of the apolipoprotein B mRNA-editing enzyme. , 2002, American journal of human genetics.

[16]  K. Grapperhaus,et al.  Ontogenic regulation of spatial differentiation in the crypt-villus axis of normal and isografted small intestine. , 1995, The American journal of physiology.

[17]  N. Davidson,et al.  Intestinal lipoprotein assembly in apobec-1-/- mice reveals subtle alterations in triglyceride secretion coupled with a shift to larger lipoproteins. , 2003, American journal of physiology. Gastrointestinal and liver physiology.

[18]  S. Kihara,et al.  Increased proportion of plasma apoB-48 to apoB-100 in non-insulin-dependent diabetic rats: contribution of enhanced apoB mRNA editing in the liver. , 1995, Journal of lipid research.

[19]  D. Cahill,et al.  Ethanol modulates apolipoprotein B mRNA editing in the rat. , 1995, Journal of lipid research.

[20]  R. Davis,et al.  Intrahepatic assembly of very low density lipoproteins. Varied synthetic response of individual apolipoproteins to fasting. , 1985, The Journal of biological chemistry.

[21]  J. Taylor,et al.  Apolipoprotein B mRNA-editing protein induces hepatocellular carcinoma and dysplasia in transgenic animals. , 1995, Proceedings of the National Academy of Sciences of the United States of America.

[22]  B. Chang,et al.  Complete Phenotypic Characterization of apobec-1 Knockout Mice with a Wild-type Genetic Background and a Human Apolipoprotein B Transgenic Background, and Restoration of Apolipoprotein B mRNA Editing by Somatic Gene Transfer of Apobec-1* , 1996, The Journal of Biological Chemistry.

[23]  G. Skuse,et al.  A potential role for NF1 mRNA editing in the pathogenesis of NF1 tumors. , 1997, American journal of human genetics.

[24]  T. Honjo,et al.  Class Switch Recombination and Hypermutation Require Activation-Induced Cytidine Deaminase (AID), a Potential RNA Editing Enzyme , 2000, Cell.

[25]  M. Elam,et al.  Stimulation of in vitro triglyceride synthesis in the rat hepatocyte by growth hormone treatment in vivo. , 1988, Endocrinology.

[26]  Ahmed Mansouri,et al.  Congenital hypothyroid Pax8(-/-) mutant mice can be rescued by inactivating the TRalpha gene. , 2002, Molecular endocrinology.

[27]  S. Kennedy,et al.  A Novel Nuclear Localization Signal in the Auxiliary Domain of Apobec-1 Complementation Factor Regulates Nucleocytoplasmic Import and Shuttling* , 2003, Journal of Biological Chemistry.

[28]  M. Perugini,et al.  Structural features of apolipoprotein B synthetic peptides that inhibit lipoprotein(a) assembly Published, JLR Papers in Press, September 16, 2004. DOI 10.1194/jlr.M400163-JLR200 , 2004, Journal of Lipid Research.

[29]  R. A. Srivastava Increased apoB100 mRNA in inbred strains of mice by estrogen is caused by decreased RNA editing protein mRNA. , 1995, Biochemical and biophysical research communications.

[30]  S. Young,et al.  Genetically modified mice for the study of apolipoprotein B. , 1998, Journal of lipid research.

[31]  V. Blanc,et al.  Isolation, characterization and developmental regulation of the human apobec-1 complementation factor (ACF) gene. , 2001, Biochimica et biophysica acta.

[32]  Wolf Reik,et al.  Mice Deficient in APOBEC2 and APOBEC3 , 2005, Molecular and Cellular Biology.

[33]  N. Davidson,et al.  Apolipoprotein B messenger RNA editing is developmentally regulated in pig small intestine: nucleotide comparison of apolipoprotein B editing regions in five species. , 1990, Biochemical and biophysical research communications.

[34]  J. Borén,et al.  Low expression of the apolipoprotein B mRNA-editing transgene in mice reduces LDL levels but does not cause liver dysplasia or tumors. , 1998, Arteriosclerosis, thrombosis, and vascular biology.

[35]  D. Mukhopadhyay,et al.  Thyroid hormone regulates hepatic triglyceride mobilization and apolipoprotein B messenger ribonucleic Acid editing in a murine model of congenital hypothyroidism. , 2003, Endocrinology.

[36]  N. Davidson,et al.  APOLIPOPROTEIN B: mRNA editing, lipoprotein assembly, and presecretory degradation. , 2000, Annual review of nutrition.

[37]  T. Innerarity,et al.  Hyperediting of Multiple Cytidines of Apolipoprotein B mRNA by APOBEC-1 Requires Auxiliary Protein(s) but Not a Mooring Sequence Motif (*) , 1996, The Journal of Biological Chemistry.

[38]  S. Olofsson,et al.  Effects of growth hormone on apolipoprotein-B (apoB) messenger ribonucleic acid editing, and apoB 48 and apoB 100 synthesis and secretion in the rat liver. , 1992, Endocrinology.

[39]  H. Brewer,et al.  Developmental Regulation of Apolipoprotein B mRNA Editing Is an Autonomous Function of Small Intestine Involving Homeobox Gene Cdx1* , 2003, The Journal of Biological Chemistry.

[40]  N. Davidson,et al.  Inhibition of N-linked glycosylation results in retention of intracellular apo[a] in hepatoma cells, although nonglycosylated and immature forms of apolipoprotein[a] are competent to associate with apolipoprotein B-100 in vitro. , 1998, Journal of lipid research.

[41]  C. Burant,et al.  Molecular cloning of an apolipoprotein B messenger RNA editing protein. , 1993, Science.

[42]  R. Hammer,et al.  Transgenic Mice Expressing Human ApoB95 and ApoB97 , 1997, The Journal of Biological Chemistry.

[43]  D. Mukhopadhyay,et al.  ARCD-1, an apobec-1-related cytidine deaminase, exerts a dominant negative effect on C to U RNA editing. , 2001, American journal of physiology. Cell physiology.

[44]  B. Mccarthy,et al.  Elimination of apolipoprotein B48 formation in rat hepatoma cell lines transfected with mutant human apolipoprotein B cDNA constructs. , 1992, The Journal of biological chemistry.

[45]  N. Navaratnam,et al.  Adenovirus-mediated gene transfer of rat apolipoprotein B mRNA-editing protein in mice virtually eliminates apolipoprotein B-100 and normal low density lipoprotein production. , 1994, The Journal of biological chemistry.

[46]  H. Greten,et al.  Apolipoprotein B mRNA editing in 12 different mammalian species: hepatic expression is reflected in low concentrations of apoB-containing plasma lipoproteins. , 1993, Journal of lipid research.

[47]  Hui Zhu,et al.  Apolipoprotein B mRNA editing is an intranuclear event that occurs posttranscriptionally coincident with splicing and polyadenylation. , 1991, The Journal of biological chemistry.

[48]  S. Kennedy,et al.  Targeted Deletion of the Murine apobec-1 Complementation Factor (acf) Gene Results in Embryonic Lethality , 2005, Molecular and Cellular Biology.

[49]  N. Davidson,et al.  Apolipoprotein B messenger RNA editing in the rat liver. Modulation by fasting and refeeding a high carbohydrate diet. , 1990, The Journal of biological chemistry.

[50]  N. Ballatori,et al.  The editosome for cytidine to uridine mRNA editing has a native complexity of 27S: identification of intracellular domains containing active and inactive editing factors. , 2002, Journal of cell science.

[51]  Z W Gu,et al.  Apolipoprotein B-48 is the product of a messenger RNA with an organ-specific in-frame stop codon. , 1987, Science.

[52]  H. Hobbs,et al.  Expression of human apolipoprotein B90 in transgenic mice. Demonstration that apolipoprotein B90 lacks the structural requirements to form lipoprotein. , 1994, The Journal of biological chemistry.

[53]  M. Hersberger,et al.  Regulatable liver expression of the rabbit apolipoprotein B mRNA-editing enzyme catalytic polypeptide 1 (APOBEC-1) in mice lacking endogenous APOBEC-1 leads to aberrant hyperediting. , 2003, The Biochemical journal.

[54]  S. Marcovina,et al.  Mutation of lysine residues in apolipoprotein B-100 causes defective lipoprotein[a] formation Published, JLR Papers in Press, September 16, 2003. DOI 10.1194/jlr.M300071-JLR200 , 2004, Journal of Lipid Research.

[55]  L. Chan,et al.  APOBEC-2, a cardiac- and skeletal muscle-specific member of the cytidine deaminase supergene family. , 1999, Biochemical and biophysical research communications.

[56]  C. Burant,et al.  Complementation of apolipoprotein B mRNA editing by human liver accompanied by secretion of apolipoprotein B48. , 1994, The Journal of biological chemistry.

[57]  M. Sowden,et al.  Regulation of hepatic apolipoprotein B RNA editing in the genetically obese Zucker rat. , 1996, Metabolism: clinical and experimental.

[58]  R. Davis,et al.  Fasting decreases apolipoprotein B mRNA editing and the secretion of small molecular weight apoB by rat hepatocytes: evidence that the total amount of apoB secreted is regulated post-transcriptionally. , 1990, Journal of lipid research.

[59]  M. Seishima,et al.  Regulation of hepatic apolipoprotein synthesis in the 17 alpha-ethinyl estradiol-treated rat. , 1991, Journal of lipid research.

[60]  J. Samarut,et al.  Involvement of T3Rα- and β-receptor subtypes in mediation of T3 functions during postnatal murine intestinal development , 1999 .

[61]  J. Morrison,et al.  Apolipoprotein B RNA editing enzyme-deficient mice are viable despite alterations in lipoprotein metabolism. , 1996, Proceedings of the National Academy of Sciences of the United States of America.

[62]  K. Weisgraber,et al.  The functional characteristics of a human apolipoprotein E variant (cysteine at residue 142) may explain its association with dominant expression of type III hyperlipoproteinemia. , 1992, The Journal of biological chemistry.

[63]  W. Li,et al.  Apolipoprotein B mRNA editing. Validation of a sensitive assay and developmental biology of RNA editing in the rat. , 1990, The Journal of biological chemistry.

[64]  N. Kakazu,et al.  Constitutive Expression of AID Leads to Tumorigenesis , 2003, The Journal of experimental medicine.

[65]  R. Davis,et al.  Intrahepatic assembly of very low density lipoproteins. Effect of fatty acids on triacylglycerol and apolipoprotein synthesis. , 1982, The Journal of biological chemistry.

[66]  S. Kennedy,et al.  Mutagenesis of Apobec-1 Complementation Factor Reveals Distinct Domains That Modulate RNA Binding, Protein-Protein Interaction with Apobec-1, and Complementation of C to U RNA-editing Activity* , 2001, The Journal of Biological Chemistry.

[67]  R. Raghow,et al.  Insulin promotes the biosynthesis and secretion of apolipoprotein B-48 by altering apolipoprotein B mRNA editing. , 1994, Proceedings of the National Academy of Sciences of the United States of America.

[68]  N. Davidson,et al.  Apolipoprotein B messenger RNA editing is developmentally regulated and widely expressed in human tissues. , 1990, The Journal of biological chemistry.

[69]  N. Davidson,et al.  Insulin increases expression of apobec-1, the catalytic subunit of the apolipoprotein B mRNA editing complex in rat hepatocytes. , 1998, Metabolism: clinical and experimental.

[70]  S. Young,et al.  Susceptibility to atherosclerosis in mice expressing exclusively apolipoprotein B48 or apolipoprotein B100. , 1997, The Journal of clinical investigation.

[71]  T. Honjo,et al.  Specific Expression of Activation-induced Cytidine Deaminase (AID), a Novel Member of the RNA-editing Deaminase Family in Germinal Center B Cells* , 1999, The Journal of Biological Chemistry.